Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up
article
OA: closed
CC0
⤵ 49 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This randomized trial with a 6-year follow-up assessed the long-term efficacy and safety of gonadotropin-releasing hormone analogs and hormone replacement therapy for endometriosis management.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (32)
- A Comparison of the Skeletal Effects of Goserelin and Danazol in Premenopausal Women with Endometriosis via openalex
- Add-back therapy in the treatment of endometriosis: the European experience. via openalex
- Correction to: "Friedman AJ, Hornstein MD: Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain. Fertil Steril 1993;60:236-41" via openalex
- GnRH Analogues in the Treatment of Endometriosis via openalex
- Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic pain via openalex
- Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists? via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- Modern Approaches to Endometriosis via openalex
- Nafarelin therapy in endometriosis: Long-term effects on bone mineral density via openalex
- Reduced Bone Mass in Reproductive-Aged Women with Endometriosis* via openalex
- Reduction of bone mineral density by gonadotropin‐releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration via openalex
- Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma via openalex
- REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. via openalex
- Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. via openalex
- W2153895111 via openalex
- W2055260481 via openalex
- W2054192093 via openalex
- W2287757320 via openalex
- W2032853276 via openalex
- W2031495520 via openalex
- W2407038112 via openalex
- W2408619637 via openalex
- W2416265216 via openalex
- W2009881284 via openalex
- W2467395168 via openalex
- W2472762831 via openalex
- W2477008945 via openalex
- W2071169126 via openalex
- W164119867 via openalex
- W2124779475 via openalex
Cited by (49)
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- Extended GnRH Agonist and NETA Add-Back: An Effective and Safe Option for Refractory Endometriosis/Adenomyosis Pain 2025
- Diagnostic Errors of Nodular Adenomyosis on the Example of a Clinical Case 2024
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Endometriosis and physical activity: A narrative review 2023
- Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis 2020
- [Progress on medical treatment in the management of adenomyosis]. 2019
- <p>Mast cell stabilizer ketotifen reduces hyperalgesia in a rodent model of surgically induced endometriosis</p> 2019
- Laparoscopic surgery with urinary tract reconstruction and bowel endometriosis resection for deep infiltrating endometriosis 2018
- Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109 2017
- Endometriosis management; A survey on medical & laparoscopic treatment 2017
- Low-dose add-back therapy during postoperative GnRH agonist treatment 2016
- Effects of cisplatin and letrozole on surgically induced endometriosis and comparison of the two medications in a rat model 2016
- Was mit konservativen Maßnahmen zu erzielen ist 2015
- Analogs of Luteinizing Hormone-Releasing Hormone in the Treatment of Endometriosis 2015
- Endometriose 2015
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
- Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis 2014
- Endometriosis – Pathogenesis, Diagnosis, and Therapeutic Options for Clinical and Ambulatory Care 2013
- Serum levels of estradiol and follicle stimulating hormone,and vasomotor symptoms in Thai women receivingGnRH analogue before laparoscopic enucleationof endometriotic cysts 2012
- Green Tea for Endometriosis 2012
- Endometriosis and Chronic Pelvic Pain 2012
- Integrated Pharmacometrics and Systems Pharmacology Model‐Based Analyses to Guide GnRH Receptor Modulator Development for Management of Endometriosis 2012
- Medical Therapies: Aromatase Inhibitors 2011
- Endometriose - Entstehung, Diagnostik, Behandlungsmöglichkeiten und Probleme in Klinik und Praxis 2011
- Clinical Aspects of Endometriosis 2010
- The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model 2010
- Gonadotropin-Releasing Hormone Agonists for Endometriosis 2008
- Selective Estrogen-Receptor Modulators and Aromatase Inhibitors: Promising New Medical Therapies for Endometriosis? 2007
- Long-term fracture risk among women with proven endometriosis 2006
- Treatment of dysfunctional uterine bleeding in the perimenopause: The effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment – a randomized, placebo-controlled, double-blind trial 2006
- GnRH analogs: Options for endometriosis-associated pain treatment 2006
- Aromatasehemmer in der Therapie der Endometriose 2006
- GnRH agonist and antagonist: Options for endometriosis pain treatment 2006
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? 2006
- Anastrazole and oral contraceptives: a novel treatment for endometriosis 2005
- The effect of physical training on bone mineral density in women with endometriosis treated with GnRH analogs: a pilot study 2005
- Add-back therapy in the treatment of endometriosis-associated pain 2004
- One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial 2004
- Medikamentöse und konservative Therapie 2004
- The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial 2003
- Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia 2003
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density 2003
- Gonadotropin Releasing Honnone Agonist and Antagonist for Endometriosis 2003
- Prolonged GnRH Agonist and Add-Back Therapy for Symptomatic Endometriosis 2002
- Endometriosis: current concepts and therapy 2002
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 2002
- Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone 2002
- The medical management of endometriosis 2002
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:13:36.046895+00:00
License: CC0
· commercial use OK